Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
2.350
-0.020 (-0.84%)
Nov 20, 2025, 10:07 AM EST - Market open
Company Description
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.
The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.
The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona.
Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.
Picard Medical, Inc.
| Country | United States |
| Founded | 1981 |
| IPO Date | Aug 29, 2025 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 75 |
| CEO | Patrick Schnegelsberg |
Contact Details
Address: 1992 E Silverlake Road Tucson, Arizona 85713 United States | |
| Phone | 520 545 1234 |
| Website | syncardia.com |
Stock Details
| Ticker Symbol | PMI |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0002030617 |
| CUSIP Number | 71953R108 |
| ISIN Number | US71953R1086 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Patrick N. J. Schnegelsberg | Chief Executive Officer and Director |
| Bernard Skaggs | Chief Financial Officer |
| Matthew Schuster | Chief Operating Officer |
| Dr. Frank Tinker Ph.D. | Chief Technology Officer of SynCardia Systems, LLC |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 19, 2025 | 8-K | Current Report |
| Nov 14, 2025 | 8-K | Current Report |
| Nov 14, 2025 | 10-Q | Quarterly Report |
| Nov 13, 2025 | SCHEDULE 13G | Filing |
| Oct 27, 2025 | 8-K | Current Report |
| Oct 14, 2025 | 8-K | Current Report |
| Sep 29, 2025 | DEF 14A | Other definitive proxy statements |
| Sep 18, 2025 | PRE 14A | Other preliminary proxy statements |
| Sep 12, 2025 | 10-Q | Quarterly Report |
| Sep 10, 2025 | 8-K | Current Report |